MultiplexDX, founded as a biotech diagnostics company, aims to revolutionize personalized molecular diagnostics. The company offers innovative diagnostic tests, including vDetect COVID- RT-qPCR, and focuses on improving diagnostics for diseases like Alzheimer's. Their core mission is to bring groundbreaking technologies to the personalized molecular diagnostics market, enhancing precision and effectiveness in disease detection and management.
Notable affiliations include partnerships with the Eastern Slovak Oncology Institute and support from the European Innovation Council (EIC). MultiplexDX has achieved significant milestones, such as becoming a proud holder of the EIC Accelerator. Their impact is evident in their contributions to advancing diagnostic technologies, particularly in response to the COVID-19 pandemic and ongoing efforts in Alzheimer's disease research.
